mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.07 |
0.1 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
IPR-456 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.1 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
0.079 |
0.1 |